Management of Tuberculosis in the Texas Prison System

Jacques Baillargeon, Michael Kelley, Michael J. Lichtenstein, Hal B. Jenson, Lannette Linthicum

Research output: Contribution to journalArticle

Abstract

Prison inmates are at increased risk of tuberculosis (TB) compared to the general population. A number of TB outbreaks have been reported in correctional settings, some of which have spread to the general community. The purpose of the present study was to describe the incidence of TB and the patterns of treatment in the Texas prison system. The incidence of TB in the Texas Department of Criminal Justice (TDCJ) prison population during a 12-month period was 27 cases per 100,000 inmates. In general, this rate persisted across each of the sociodemographic groups under study, but was 15-fold greater among HIV-infected inmates (395 cases per 100,000). Overall, 59% of the sample were prescribed antitubercular therapy for at least the defined standard duration; 45% were prescribed anti-TB therapy for longer than the standard duration; ethambutol was included in the initial therapy among 95% of inmates treated with anti-TB therapy; and approximately 33% were prescribed pyrazinamide for a period of less than 56 days. Approximately 36% of the study sample began antitubercular pharmacotherapy prior to incarceration, while 7% were released from prison prior to completion of their therapy. In view of previously reported prison-to-general-community TB transmission, understanding TB prevalence and treatment patterns in correctional settings holds clinical and public health relevance beyond the prison setting.

Original languageEnglish (US)
Pages (from-to)77-93
Number of pages17
JournalJournal of Correctional Health Care
Volume9
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Prisons
Tuberculosis
Therapeutics
Pyrazinamide
Ethambutol
Criminal Law
Incidence
Population
Disease Outbreaks
Public Health
HIV
Drug Therapy

ASJC Scopus subject areas

  • Community and Home Care
  • Public Health, Environmental and Occupational Health

Cite this

Management of Tuberculosis in the Texas Prison System. / Baillargeon, Jacques; Kelley, Michael; Lichtenstein, Michael J.; Jenson, Hal B.; Linthicum, Lannette.

In: Journal of Correctional Health Care, Vol. 9, No. 1, 2002, p. 77-93.

Research output: Contribution to journalArticle

Baillargeon, Jacques ; Kelley, Michael ; Lichtenstein, Michael J. ; Jenson, Hal B. ; Linthicum, Lannette. / Management of Tuberculosis in the Texas Prison System. In: Journal of Correctional Health Care. 2002 ; Vol. 9, No. 1. pp. 77-93.
@article{baae110fbda64ff78a55b2854930ea08,
title = "Management of Tuberculosis in the Texas Prison System",
abstract = "Prison inmates are at increased risk of tuberculosis (TB) compared to the general population. A number of TB outbreaks have been reported in correctional settings, some of which have spread to the general community. The purpose of the present study was to describe the incidence of TB and the patterns of treatment in the Texas prison system. The incidence of TB in the Texas Department of Criminal Justice (TDCJ) prison population during a 12-month period was 27 cases per 100,000 inmates. In general, this rate persisted across each of the sociodemographic groups under study, but was 15-fold greater among HIV-infected inmates (395 cases per 100,000). Overall, 59{\%} of the sample were prescribed antitubercular therapy for at least the defined standard duration; 45{\%} were prescribed anti-TB therapy for longer than the standard duration; ethambutol was included in the initial therapy among 95{\%} of inmates treated with anti-TB therapy; and approximately 33{\%} were prescribed pyrazinamide for a period of less than 56 days. Approximately 36{\%} of the study sample began antitubercular pharmacotherapy prior to incarceration, while 7{\%} were released from prison prior to completion of their therapy. In view of previously reported prison-to-general-community TB transmission, understanding TB prevalence and treatment patterns in correctional settings holds clinical and public health relevance beyond the prison setting.",
author = "Jacques Baillargeon and Michael Kelley and Lichtenstein, {Michael J.} and Jenson, {Hal B.} and Lannette Linthicum",
year = "2002",
doi = "10.1177/107834580200900108",
language = "English (US)",
volume = "9",
pages = "77--93",
journal = "Journal of Correctional Health Care",
issn = "1078-3458",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Management of Tuberculosis in the Texas Prison System

AU - Baillargeon, Jacques

AU - Kelley, Michael

AU - Lichtenstein, Michael J.

AU - Jenson, Hal B.

AU - Linthicum, Lannette

PY - 2002

Y1 - 2002

N2 - Prison inmates are at increased risk of tuberculosis (TB) compared to the general population. A number of TB outbreaks have been reported in correctional settings, some of which have spread to the general community. The purpose of the present study was to describe the incidence of TB and the patterns of treatment in the Texas prison system. The incidence of TB in the Texas Department of Criminal Justice (TDCJ) prison population during a 12-month period was 27 cases per 100,000 inmates. In general, this rate persisted across each of the sociodemographic groups under study, but was 15-fold greater among HIV-infected inmates (395 cases per 100,000). Overall, 59% of the sample were prescribed antitubercular therapy for at least the defined standard duration; 45% were prescribed anti-TB therapy for longer than the standard duration; ethambutol was included in the initial therapy among 95% of inmates treated with anti-TB therapy; and approximately 33% were prescribed pyrazinamide for a period of less than 56 days. Approximately 36% of the study sample began antitubercular pharmacotherapy prior to incarceration, while 7% were released from prison prior to completion of their therapy. In view of previously reported prison-to-general-community TB transmission, understanding TB prevalence and treatment patterns in correctional settings holds clinical and public health relevance beyond the prison setting.

AB - Prison inmates are at increased risk of tuberculosis (TB) compared to the general population. A number of TB outbreaks have been reported in correctional settings, some of which have spread to the general community. The purpose of the present study was to describe the incidence of TB and the patterns of treatment in the Texas prison system. The incidence of TB in the Texas Department of Criminal Justice (TDCJ) prison population during a 12-month period was 27 cases per 100,000 inmates. In general, this rate persisted across each of the sociodemographic groups under study, but was 15-fold greater among HIV-infected inmates (395 cases per 100,000). Overall, 59% of the sample were prescribed antitubercular therapy for at least the defined standard duration; 45% were prescribed anti-TB therapy for longer than the standard duration; ethambutol was included in the initial therapy among 95% of inmates treated with anti-TB therapy; and approximately 33% were prescribed pyrazinamide for a period of less than 56 days. Approximately 36% of the study sample began antitubercular pharmacotherapy prior to incarceration, while 7% were released from prison prior to completion of their therapy. In view of previously reported prison-to-general-community TB transmission, understanding TB prevalence and treatment patterns in correctional settings holds clinical and public health relevance beyond the prison setting.

UR - http://www.scopus.com/inward/record.url?scp=84990339202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990339202&partnerID=8YFLogxK

U2 - 10.1177/107834580200900108

DO - 10.1177/107834580200900108

M3 - Article

VL - 9

SP - 77

EP - 93

JO - Journal of Correctional Health Care

JF - Journal of Correctional Health Care

SN - 1078-3458

IS - 1

ER -